Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
GCTK

GCTK - GlucoTrack, Inc. Stock Price, Fair Value and News

$3.43+0.02 (+0.59%)
Market Closed

69/100

GCTK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

69/100

GCTK

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$5.06

Target 3M

$3.94

Target 6M

$4.28

GCTK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GCTK Price Action

Last 7 days

-12.3%

Last 30 days

-11.4%

Last 90 days

-46.7%

Trailing 12 Months

-96.9%

GCTK RSI Chart

GCTK Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GCTK Valuation

Market Cap

3.1M

Price/Earnings (Trailing)

-0.12

Price/Sales (Trailing)

25.79

Price/Free Cashflow

-0.21

GCTK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$5.06

Target 3M

$3.94

Target 6M

$4.28

GCTK Fundamentals

GCTK Revenue

Revenue (TTM)

208.0K

GCTK Earnings

Earnings (TTM)

-25.9M

Earnings Growth (Yr)

18.01%

Earnings Growth (Qtr)

12.3%

GCTK Profitability

Return on Equity

-939.8%

Return on Assets

-311.87%

Free Cashflow Yield

-476.33%

GCTK Investor Care

Shares Dilution (1Y)

19188.23%

Diluted EPS (TTM)

2.0K

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20230000
20200000
201940.8K136.1K140.3K208.0K
2018562.5K486.9K466.0K43.5K
2017618.8K327.9K337.5K630.5K
2016156.5K470.9K482.2K611.7K
201580.6K101.5K122.3K143.2K
201400059.8K
Get all data in R, Python etc through our Historical Stock Data APIs

About GlucoTrack, Inc.

GCTK
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
 WEBSITEhttps://glucotrack.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES3

GlucoTrack, Inc. Frequently Asked Questions

GCTK is the stock ticker symbol of GlucoTrack, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of GlucoTrack, Inc. is 3.12 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check GCTK's fair value in chart for subscribers.

The fair value guage provides a quick view whether GCTK is over valued or under valued. Whether GlucoTrack, Inc. is cheap or expensive depends on the assumptions which impact GlucoTrack, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GCTK.

As of Wed Jan 28 2026, GCTK's PE ratio (Price to Earnings) is -0.12 and Price to Sales (PS) ratio is 25.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GCTK PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, GlucoTrack, Inc. has provided -0.684 (multiply by 100 for percentage) rate of return.